More collection sites equal more revenue & higher SP Medivolve share price should start moving up with more testing sites coming online. Medivolve should have 87 collection sites generating revenue compared to 54 last week. Percentage-wise, this is about a 62% increase. All this means Over a 60% increase in revenue. Any increase in the revenue usually is reflected in the share price.
Also, anyone shorting MEDV should be more careful shorting or even start covering any short. As with increased revenue, investors will start taking notice. 87 collection sites with the lowest announced numbers of 75 tests per site can bring in big money for Medivolve.
Here is a little example 87x75=6525 tests per day and 195,750 tests per month, and with an average of $95 per test, can generate USD 18,596,250 per month. Converting this to Canadian is about 18,596,250x1.28= $23,803,200 CAD per month. Collection sites with 87 testing sites can generate $285,638,400 per year. Keep in mind for this probably take 3-4 weeks for people to know about these sites. So, we add 3-4 weeks to reach 75 tests per site, average numbers.
Once they complete the second phase. The third phase is to add another 70 collection sites https://medivolve.ca/investor-presentation/. So progress does not start here.
Also, with all this money, Medivolve can start investing in other technologies like they did last week in Marvel Diagnostics Inc https://medivolve.ca/medivolve-announces-investment-into-marvel-diagnostics-and-its-non-invasive-exhaled-breath-diagnostic-technology/